Literature DB >> 8248246

Structure and promoter characterization of the gene encoding the large subunit (R1 protein) of mouse ribonucleotide reductase.

S Björklund1, K Hjortsberg, E Johansson, L Thelander.   

Abstract

Mammalian ribonucleotide reductase (EC 1.17.4.1) is composed of two nonidentical subunits, proteins R1 and R2, both required for enzyme activity. The structure of the genomic mouse ribonucleotide reductase R1 gene was compiled from a number of overlapping lambda clones isolated from a Charon 4A mouse sperm genomic library. The R1-encoding gene covers 26 kb and consists of 19 exons. All exon-intron boundaries were located by dideoxynucleotide sequencing, showing that intron 7 starts with the variant GC instead of GT. About 3.5 kb of DNA from the 5'-flanking region of the R1-encoding gene were cloned and sequenced, and the transcriptional start site was determined by nuclease S1 mapping of RNA. DNase I footprinting assays on the R1 promoter identified two nearly identical 23-bp-long protein-binding regions. Three protein complexes binding to one of the 23-mer regions were resolved and partially identified by using gel-retardation mobility-shift assays and UV crosslinking. One complex most likely contained Sp1, and another complex showed S-phase-specific binding, suggesting a direct role in the cell-cycle-dependent R1 gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8248246      PMCID: PMC47974          DOI: 10.1073/pnas.90.23.11322

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  An improved nuclear extract preparation method.

Authors:  K Zerivitz; G Akusjärvi
Journal:  Gene Anal Tech       Date:  1989 Sep-Oct

2.  S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs.

Authors:  S Björklund; S Skog; B Tribukait; L Thelander
Journal:  Biochemistry       Date:  1990-06-12       Impact factor: 3.162

3.  Inducible proteins binding to the murine thymidine kinase promoter in late G1/S phase.

Authors:  Q P Dou; J L Fridovich-Keil; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

4.  Cloned mouse ribonucleotide reductase subunit M1 cDNA reveals amino acid sequence homology with Escherichia coli and herpesvirus ribonucleotide reductases.

Authors:  I W Caras; B B Levinson; M Fabry; S R Williams; D W Martin
Journal:  J Biol Chem       Date:  1985-06-10       Impact factor: 5.157

5.  Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation.

Authors:  G J Mann; E A Musgrove; R M Fox; L Thelander
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

Review 6.  Interactions between deoxyribonucleotide and DNA synthesis.

Authors:  P Reichard
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

7.  Mouse thymidine kinase: the promoter sequence and the gene and pseudogene structures in normal cells and in thymidine kinase deficient mutants.

Authors:  C Seiser; M Knöfler; I Rudelstorfer; R Haas; E Wintersberger
Journal:  Nucleic Acids Res       Date:  1989-01-11       Impact factor: 16.971

8.  Maximal binding levels of an H1 histone gene-specific factor in S-phase correlate with maximal H1 gene transcription.

Authors:  S Dalton; J R Wells
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

9.  An S-phase specific release from a transcriptional block regulates the expression of mouse ribonucleotide reductase R2 subunit.

Authors:  S Björklund; E Skogman; L Thelander
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

10.  Molecular cloning and expression of the functional gene encoding the M2 subunit of mouse ribonucleotide reductase: a new dominant marker gene.

Authors:  M Thelander; L Thelander
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  3 in total

1.  Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes.

Authors:  J DeGregori; T Kowalik; J R Nevins
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

2.  A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study.

Authors:  Mark H Kirschbaum; Paul Frankel; Timothy W Synold; Zhiliang Xie; Yun Yen; Leslie Popplewell; Robert Chen; Omar Aljitawi; Joseph M Tuscano; Kenneth K Chan; Edward M Newman
Journal:  Leuk Lymphoma       Date:  2016-02-19

3.  Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential.

Authors:  B S Zhou; P Tsai; R Ker; J Tsai; R Ho; J Yu; J Shih; Y Yen
Journal:  Clin Exp Metastasis       Date:  1998-01       Impact factor: 4.510

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.